## **Core Concept**
Adenosine deaminase (ADA) inhibitors are a class of drugs used primarily in the treatment of certain types of leukemia and lymphoma. They work by inhibiting the enzyme adenosine deaminase, which is crucial for the breakdown of adenosine and deoxyadenosine in cells. Accumulation of these substances is particularly toxic to lymphocytes.

## **Why the Correct Answer is Right**
The correct answer, , refers to a specific drug that inhibits adenosine deaminase. This drug, also known as cladribine or deoxycoformycin, is a potent inhibitor of adenosine deaminase. By inhibiting this enzyme, cladribine leads to the accumulation of dATP, which is toxic to lymphocytes, thereby exerting its therapeutic effect in certain hematological malignancies.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because it does not correspond to a known adenosine deaminase inhibitor.
- **Option B:** - This option is incorrect because it does not accurately represent a drug classified as an adenosine deaminase inhibitor.
- **Option D:** - This option is incorrect because it does not refer to a drug that functions by inhibiting adenosine deaminase.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that adenosine deaminase inhibitors, such as cladribine, are particularly effective in treating hairy cell leukemia, a type of cancer that affects the blood and bone marrow. These drugs have significantly improved the treatment outcomes for patients with this condition.

## **Correct Answer:** .